Ivan Ulč

Validated HPLC–MS–MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma—pharmacokinetic study

V. Bořek-Dohalský, Jitka Huclová, B. Barrett et al. · Analytical and Bioanalytical Chemistry · 2006 · 71 citations

Therapeutic Drug Monitoring, Medicine, Hplc–ms–ms Method +8

Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group

Günther Krumpl, Ivan Ulč, Michaela Trebs et al. · European Journal of Clinical Pharmacology · 2017 · 36 citations

Healthy Caucasian Group, Pharmacological Study, Pharmacodynamic Profiles +6

Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment

Patricia N. Sidharta, Nicolas Lindegger, Ivan Ulč et al. · The Journal of Clinical Pharmacology · 2013 · 35 citations

Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of Simvastatin

Tom B. Vree, Erik Dammers, Ivan Ulč et al. · The Scientific World JOURNAL · 2003 · 32 citations · Full text

Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment

Priska Kaufmann, Hans G. Cruz, Andreas Krause et al. · British Journal of Clinical Pharmacology · 2016 · 28 citations · Full text